Nafarelin is a potent agonistic analog of gonadotropin-releasing hormone (GnRH). Nafarelin has been used in the treatments of central precocious puberty and endometriosis.
This report contains market size and forecasts of Nafarelin in global, including the following market information:
Global Nafarelin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nafarelin Market Sales, 2017-2022, 2023-2028, (g)
Global top five Nafarelin companies in 2021 (%)
The global Nafarelin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nasal Spray Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nafarelin include Pfizer, Shanghai Soho-Yiming Pharmaceuticals, CPC Scientific and Hangzhou Longshine Bio-Tech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nafarelin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nafarelin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (g)
Global Nafarelin Market Segment Percentages, by Type, 2021 (%)
Nasal Spray
Freeze-dried Powder
Global Nafarelin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (g)
Global Nafarelin Market Segment Percentages, by Application, 2021 (%)
Central Precocious Puberty
Endometriosis
Global Nafarelin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (g)
Global Nafarelin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nafarelin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nafarelin revenues share in global market, 2021 (%)
Key companies Nafarelin sales in global market, 2017-2022 (Estimated), (g)
Key companies Nafarelin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Shanghai Soho-Yiming Pharmaceuticals
CPC Scientific
Hangzhou Longshine Bio-Tech